Ariane Tom, PhD's Linkedin Analytics

Dr. Ariane Tom is Founding Partner of Kaleida Capital, investing in early-stage startups in precision neuroscience and neurotechnology. Throughout her academic career at Stanford, Ariane spearheaded interdisciplinary research programs in neural interfaces with applications in brain-mapping, prosthetics, drug delivery, and neuromodulation. She is a published co-author in top-tier research journals Science Magazine and Nature Portfolio with Karl Deisseroth and Zhenan Bao (h-indexes 171, 194, respectively). As a neurotechnology innovation thought leader, she is a frequent speaker at events where she discusses neurotechnology development and investment landscape. She has applied over a decade of research insight to venture capital, patent law, and public policy, cultivating a top-performing investment track record in biotechnology. She has served as a Board Observer for companies spanning neuroimaging, cancer diagnostics, drug discovery, and immunotherapy. Ariane holds a B.S. in Materials Science & Engineering, an M.S. in Bioengineering, and a Ph.D. in Bioengineering, all from Stanford University.